Incorporated in 1992, Neurocrine Biosciences is a product-based biopharmaceutical Company focused on neurological and endocrine diseases and disorders. Its product candidates address some of the largest pharmaceutical markets in the world including insomnia, anxiety, depression, diabetes, irritable bowel syndrome, and autoimmunity. Neurocrine Biosciences goal is to become the leading therapeutic product-based biopharmaceutical company focused on neurologic and endocrine diseases and disorders. They are committed to bring novel drugs and innovative new treatments through development as rapidly as possible to bring new hope to the patient and value to their shareholders.